Asset Planning Corporation’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
Asset Planning Corporation's BMY Position: Q1 2021 in Review
Asset Planning Corporation sold out of Bristol-Myers Squibb (BMY) in Q1 2021, closing a stake of 1,661 shares — an estimated $103K sold.
Asset Planning Corporation first reported a position in BMY in Q4 2020 and held it in 1 quarter. The position peaked at $103K in Q4 2020. 2,368 funds tracked by Wall St. Rank hold BMY as of Q1 2021.
- Asset Planning Corporation reported no remaining Bristol-Myers Squibb position as of Q1 2021 after selling out during the quarter.
- Asset Planning Corporation sold 1,661 Bristol-Myers Squibb shares in Q1 2021, an estimated $103K.
- Asset Planning Corporation first reported a position in Bristol-Myers Squibb in Q4 2020 and held it in 1 quarter.
- Asset Planning Corporation's Bristol-Myers Squibb position peaked at $103K in Q4 2020.
- 2,368 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2021.
Based on Asset Planning Corporation's 13F filing for Q1 2021, filed 17 May 2021.